Capital Markets

• Shanghai REFIRE Group Limited (2570.HK) in its approximately US$91 million IPO and listing on the Hong Kong Stock Exchange
• Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK) in its approximately US$43 million IPO and listing on the Hong Kong Stock Exchange
• TYK Medicines in its approximately US$74 million IPO and listing on the Hong Kong Stock Exchange
• Ruichang International Holdings Limited in its approximately US$17 million IPO and listing on the Hong Kong Stock Exchange
• Sunho Biologics in Approximately US$60 Million IPO and listing on the Hong Kong Stock Exchange
• Cryofocus Medtech (Shanghai) Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
• Jenscare Scientific Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
• Rainmed Medical Limited in its IPO and listing on the Hong Kong Stock Exchange
• Goldman Sachs, J.P. Morgan and Jefferies on the US$400 million global offering and listing of JHBP (CY) Holdings on the Hong Kong Stock Exchange
• Morgan Stanley and J.P. Morgan on the US$415 million global offering and listing of Baoxin Auto Group Limited on the Hong Kong Stock Exchange
• Morgan Stanley and Nomura on the US$1.35 billion global offering and listing of Chongqing Rural Commercial Bank Co., Ltd. on the Hong Kong Stock Exchange
• CMGE Technology Group Limited in its US$191 million global offering and listing on the Hong Kong Stock Exchange
• Tencent Holdings Limited in its spin-off of China Literature Limited by way of a US$919.2 million IPO and separate listing of China Literature Limited on the Hong Kong Stock Exchange
• Yihai International Holding Ltd. (sole supplier of hot pot soup flavoring products to Haidilao) it its US$111 million global offering and listing on the Hong Kong Stock Exchange
• Red Star Macalline Group Corporation Ltd. in its US$931 million global offering and listing on the Hong Kong Stock Exchange
• Oaktree Capital Management, L.P. as a cornerstone investor in the global offering and listing of JW (Cayman) Therapeutics Co. Ltd, Kangji Medical Holdings Limited and Pharmaron Beijing Co., Ltd on the Hong Kong Stock Exchange
• SinoMedia Company Limited in its global offering and listing on the Hong Kong Stock Exchange
• Shandong Molong Petroleum Machinery Company Limited in its migration from GEM to the Main Board of the Hong Kong Stock Exchange
• Haitong International Securities Group Limited on a loan capitalization issue to its controlling shareholder and the subsequent offer for sale of capitalization shares by the controlling shareholder

Mergers & Acquisitions

• Aluminum Corporation of China Limited in its US$326 million privatization of Chinalco Mining Corporation International
• Sinopharm Group Hongkong Co., Limited, a wholly owned subsidiary of China National Pharmaceutical Group Corporation, in its US$332 million voluntary conditional cash offer for and takeover of Winteam Pharmaceutical Group Limited on the Hong Kong Stock Exchange
• Yihai International Holding Ltd. in its pre-IPO investments by Yunfeng Fund, Greenwoods Bloom Fund and New Hope Agriculture and Food Fund
• SinoMedia Company Limited in its pre-IPO series A shares financing with Bain Capital as the investor
• A leading Hong Kong commercial banking group in its proposed sale of shares in VISA and MasterCard
• A leading worldwide express delivery company in its proposed acquisition of certain domestic express delivery business in Mainland China, Hong Kong and Taiwan
• Shandong Molong Petroleum Machinery Company Limited in its major and connected transaction for the acquisition of Shouguang Maolong Machinery Electric Co., Ltd.

Compliance

• SINOPEC Engineering (Group) Co., Ltd., CMGE Technology Group Limited, PetroChina Company Limited, Weiqiao Textile Company Limited, Shandong Molong Petroleum Machinery Company Limited, and Hainan Meilan International Airport Company Limited on continuing obligations under the Hong Kong Listing Rules